Musso Alan A 4
4 · BELLICUM PHARMACEUTICALS, INC · Filed Jan 4, 2018
Insider Transaction Report
Form 4
Musso Alan A
CFO and Treasurer
Transactions
- Award
Employee Stock Option (right to buy)
2018-01-02+22,500→ 22,500 totalExercise: $9.23Exp: 2028-01-01→ Common Stock (22,500 underlying) - Award
Restricted Stock Units
2018-01-02+12,500→ 12,500 total→ Common Stock (12,500 underlying)
Footnotes (3)
- [F1]25% of the shares subject to the stock option vest and become exercisable on January 2, 2019, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of BLCM common stock.
- [F3]The restricted stock units vest in four equal annual installments beginning January 2, 2019.